Emtricitabine 69097-0642-02
- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 31, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA091168
Need to source Emtricitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Emtricitabine | 200 mg/1 |
Drug Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Reverse Transcriptase Inhibitors [MoA]
Selected Package
69097-0642-02Selected30 CAPSULE in 1 BOTTLE (69097-642-02)
Other packages for this product(1)
1000 CAPSULE in 1 BOTTLE (69097-642-15)